🇺🇸 FDA
Pipeline program

SSGJ-707

SSGJ-707-NSCLC-III-01

Phase 3 small_molecule active

Quick answer

SSGJ-707 for Advanced Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Advanced Non-Small Cell Lung Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials